A case of new onset refractory status epilepticus in a US traveler with Japanese encephalitis

被引:0
|
作者
Osbourn, Spencer R. [1 ]
Ryan, Keith E. [1 ]
Cannard, Kevin R. [1 ]
Ma, Yitao [1 ]
机构
[1] Walter Reed Natl Mil Med Ctr, Dept Neurol, 8901 Wisconsin Ave, Bethesda, MD 20889 USA
关键词
Japanese encephalitis; NORSE; Anti-NMDAR encephalitis; RECEPTOR ENCEPHALITIS; SEIZURES;
D O I
10.1016/j.jneuroim.2023.578193
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
New onset refractory status epilepticus (NORSE) is a rare but critical condition characterized by refractory status epilepticus (RSE) in an individual without prior history of epilepsy or known structural, toxic, or metabolic cause. Postinfectious immune activation is an important cause of NORSE. Early testing for autoimmune antibodies is strongly recommended (Wickstrom et al., 2022). We report a case of NORSE triggered by Japanese encephalitis (JE) in an unvaccinated US adult traveler. Her CSF later revealed positive anti-N-methyl-D-aspartate (NMDA)-receptor antibody. The patient responded well to first line immunotherapy with favorable functional outcome. This case highlights the diagnostic and treatment challenges in this rare presentation.
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Cytokines in new-onset refractory status epilepticus: ready for clinical use?
    Jin, Zhenghan
    Zhan, Yixin
    Chen, Shijia
    Zheng, Yang
    ACTA EPILEPTOLOGICA, 2024, 6 (01):
  • [32] New-onset refractory status epilepticus after first dose of tozinameran
    Tan, You-Jiang
    Sim, Chun Yang
    Narasimhalu, Kaavya
    Lim, Kheng Seang
    NEUROLOGY ASIA, 2022, 27 (03) : 771 - 776
  • [33] New-Onset Refractory Status Epilepticus Associated With the Use of Synthetic Cannabinoids
    Patel, Neil A.
    Jerry, Jason M.
    Jimenez, Xavier F.
    Hantus, Stephen T.
    PSYCHOSOMATICS, 2017, 58 (02) : 180 - 186
  • [34] Early-onset status epilepticus in patients with acute encephalitis
    Sonneville, Romain
    Mariotte, Eric
    Neuville, Mathilde
    Minaud, Sebastien
    Magalhaes, Eric
    Ruckly, Stephane
    Cantier, Marie
    Voiriot, Guillaume
    Radjou, Aguila
    Smonig, Roland
    Soubirou, Jean-Francois
    Mourvillier, Bruno
    Bouadma, Lila
    Wolff, Michel
    Timsit, Jean-Francois
    MEDICINE, 2016, 95 (30)
  • [35] New Developments in Refractory Status Epilepticus
    Datar, Sudhir
    NEUROSURGERY CLINICS OF NORTH AMERICA, 2018, 29 (02) : 273 - +
  • [36] New Developments in Refractory Status Epilepticus
    Datar, Sudhir
    NEUROLOGIC CLINICS, 2017, 35 (04) : 751 - +
  • [37] Microdialysis Findings in a Patient with New Onset Refractory Non-convulsive Status Epilepticus
    Hurth, Helene
    Schlak, Dennis
    Ebner, Florian Heinrich
    NEUROCRITICAL CARE, 2020, 32 (03) : 889 - 893
  • [38] New onset refractory status epilepticus: Long-term outcomes beyond seizures
    Espino, Poul H.
    Eschbach, Krista
    Blank, Leah J.
    Cervenka, Mackenzie C.
    Muscal, Eyal
    Farias-Moeller, Raquel
    Gilmore, Emily J.
    Gopaul, Margaret T.
    Haider, Hiba A.
    Hanin, Aurelie
    Hirsch, Lawrence J.
    Kellogg, Marissa A.
    Kluger, Gerhard
    Lee, Soon-Tae
    Melendez-Zaidi, Alexandria E.
    Navarro, Vincent
    Oliger, Audrey C.
    Pasini, Elena
    Reuner, Gitta
    Sharpe, Cynthia M.
    Sheikh, Zubeda B.
    Steigleder, Leon
    Steriade, Claude
    Stredny, Coral M.
    Strzelczyk, Adam
    Taraschenko, Olga
    van Baalen, Andreas
    Vinette, Sarah A.
    Wickstroem, Ronny
    Wong, Nora W.
    Yoo, Jiyeoun
    Gofton, Teneille E.
    EPILEPSIA, 2025, : 988 - 1005
  • [39] Dramatic response to delayed treatment with tocilizumab in new-onset refractory status epilepticus
    Pasqualini, Nicholas
    Falcicchio, Giovanni
    Vogrig, Alberto
    Pellicciari, Roberta
    Defazio, Giovanni
    Gelormini, Domenico
    Liviero, Marilena Casartelli
    Gottin, Leonardo
    Bonetti, Bruno
    Zivelonghi, Cecilia
    Ferlisi, Monica
    Zanoni, Tiziano
    NEUROLOGICAL SCIENCES, 2025,
  • [40] Overview of new-onset refractory status epilepticus: current concepts, diagnosis, and management
    Wickstrom, Ronny
    CLINICAL EPILEPTOLOGY, 2023, 36 (04) : 298 - 303